New Blood Tests for Multiple Cancers Screening

The Vanguard Study: Testing a New Way to Screen for Cancer

Recruiting N/A Interventional Study
Bladder Carcinoma Breast Carcinoma Colorectal Carcinoma Esophageal Carcinoma Gastric Carcinoma Liver Carcinoma Lung Carcinoma Malignant Solid Neoplasm Ovarian Carcinoma Pancreatic Carcinoma Prostate Carcinoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
45 – 75
Sex
Any
Study type
Interventional
Purpose
Screening
Participants needed
24,000 (estimated)
Sponsor
National Cancer Institute (NCI) · NIH
Who this trial is looking for

This trial is looking for adults aged 45 to 75 who do not have cancer. Participants will provide blood samples for tests that screen for several types of cancer at once.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am aged 45 to 75 years old.
  • I agree to provide blood samples for testing.
  • I agree to allow my medical records to be used for this study.
  • I can understand and complete consent forms in English, Spanish, or Arabic.

You may not be able to join if

  • I have been diagnosed with a solid malignant tumor or blood cancer in the last 5 years.
  • I am currently undergoing tests to diagnose cancer.
  • I am participating in another study about a cancer screening test.
  • I am currently pregnant, breastfeeding, or planning to become pregnant within the next year.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial. An MCD test measures markers in the blood in order to screen for multiple cancers simultaneously. There is a need to understand how MCDs may work as cancer screening tools. The goal of cancer screening is to reduce the burden of c…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Ages 45-75 years old * Agree to provide blood samples for possible MCD testing at enrollment and at 1 year following enrollment * Agree to allow collection of information from their medical records for study-related purposes * Understand and be able to complete informed consen…
Contacts

No contact information available.